Le Shen
No. 155, Hanzhong Road
Nanjing, 210004, China
Nanjing, 210004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Non-HDL-C/HDL-C Ratio and N-Terminal Pro-B-Type Natriuretic Peptide in the general and hospital-based population: a cross-sectional validation study.
Journal: Frontiers in endocrinology
Published: November 05, 2025
Associations of triglyceride-glucose index with N-terminal pro-B-type natriuretic peptide and mortality in middle-aged and elderly individuals.
Journal: Frontiers in endocrinology
Published: July 01, 2025
Associations of cardiac biomarkers with chronic kidney disease and mortality in US individuals without prevalent cardiovascular disease.
Journal: Scientific reports
Published: July 05, 2024
Associations of elevated cardiac biomarkers with hyperuricemia and mortality in US adults without prevalent cardiovascular disease.
Journal: Frontiers in endocrinology
Published: May 13, 2024
Tanshinone IIA Protects Ischemia/Reperfusion-Induced Cardiomyocyte Injury by Inhibiting the HAS2/FGF9 Axis.
Journal: Cardiology research and practice
Published: April 15, 2024
Integrated bioinformatics and experiment revealed that cuproptosis is the potential common pathogenesis of three kinds of primary cardiomyopathy.
Journal: Aging
Published: June 22, 2023
Baroreflex activation therapy for heart failure with reduced ejection fraction: A comprehensive systematic review and meta-analysis.
Journal: Heliyon
Published: June 03, 2023
Evaluation the role of cuproptosis-related genes in the pathogenesis, diagnosis and molecular subtypes identification of atherosclerosis.
Journal: Heliyon
Published: May 05, 2023
The association between the thyroid feedback quantile-based index and serum uric acid in U.S. adults.
Journal: European journal of medical research
Published: November 03, 2022
Plasma S-Klotho level affects the risk of hyperuricemia in the middle-aged and elderly people.
Journal: European journal of medical research
Published: August 25, 2022
Qihuang Zhuyu Formula Attenuates Atherosclerosis via Targeting PPARγ to Regulate Cholesterol Efflux and Endothelial Cell Inflammation.
Journal: Oxidative medicine and cellular longevity
Published: July 07, 2022
Xinkeshu for coronary heart disease complicated with anxiety or depression: A meta-analysis of randomized controlled trials.
Journal: Journal of ethnopharmacology
Published: May 13, 2022
Last Updated: 09/26/2026